![]() |
|
|
Department of Internal Medicine, Division of Hematology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201
* To whom correspondence should be addressed. E-mail: prasada{at}karmanos.org.
Zinc deficiency in humans decreases the activity of serum thymulin (a thymic hormone), which is required for maturation of T-helper cells. T-helper 1 (Th1) cytokines are decreased but T-helper 2 (Th2) cytokines are not affected by zinc deficiency in humans. This shift of Th1 to Th2 function results in cell-mediated immune dysfunction. Because IL-2 production (Th1 cytokine) is decreased, this leads to decreased activities of natural-killer cell and T cytolytic cells, which are involved in killing viruses, bacteria, and tumor cells. In humans, zinc deficiency may decrease the generation of new CD4+ T cells from the thymus. In cell culture studies (HUT-78, a Th0 human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-
B (NF-
B) activation, phosphorylation of I
B, and binding of NF-
B to DNA are decreased and this results in decreased Th1 cytokine production. In another study, zinc supplementation to humans decreased the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-
, IL-1ß, and IL-8 cytokines and mRNA. In these cells, zinc induced A20, a zinc finger protein that inhibited NF-
B activation via tumor necrosis factor receptor associated factor pathway, and this decreased gene expression of pro-inflammatory cytokines and oxidative stress markers. We conclude that zinc has an important role in cell-mediated immune functions and also functions as antiinflammatory and antioxidant agent.
This article has been cited by other articles:
![]() |
S. Taneja, N. Bhandari, T. Rongsen-Chandola, D. Mahalanabis, O. Fontaine, and M. K. Bhan Effect of zinc supplementation on morbidity and growth in hospital-born, low-birth-weight infants Am. J. Clinical Nutrition, August 1, 2009; 90(2): 385 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marian and G. Sacks Micronutrients and Older Adults Nutr Clin Pract, April 1, 2009; 24(2): 179 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H Sandstead, A. S Prasad, J. G Penland, F. W. Beck, J. Kaplan, N. G Egger, N. W Alcock, R. M Carroll, V. Ramanujam, H. H Dayal, et al. Zinc deficiency in Mexican American children: influence of zinc and other micronutrients on T cells, cytokines, and antiinflammatory plasma proteins Am. J. Clinical Nutrition, October 1, 2008; 88(4): 1067 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shen, E. Oesterling, A. Stromberg, M. Toborek, R. MacDonald, and B. Hennig Zinc Deficiency Induces Vascular Pro-Inflammatory Parameters Associated with NF-{kappa}B and PPAR Signaling J. Am. Coll. Nutr., October 1, 2008; 27(5): 577 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Berger Zinc: A Key Pharmaconutrient in Critically Ill Patients? JPEN J Parenter Enteral Nutr, September 1, 2008; 32(5): 582 - 584. [Full Text] [PDF] |
||||
![]() |
D. K. Heyland, N. Jones, N. Z. Cvijanovich, and H. Wong Zinc Supplementation in Critically Ill Patients: A Key Pharmaconutrient? JPEN J Parenter Enteral Nutr, September 1, 2008; 32(5): 509 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Cave, R. T. Hurt, T. H. Frazier, P. J. Matheson, R. N. Garrison, C. J. McClain, and S. A. McClave Obesity, Inflammation, and the Potential Application of Pharmaconutrition Nutr Clin Pract, February 1, 2008; 23(1): 16 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Prentice, H. Ghattas, and S. E. Cox Host-Pathogen Interactions: Can Micronutrients Tip the Balance? J. Nutr., May 1, 2007; 137(5): 1334 - 1337. [Abstract] [Full Text] [PDF] |
||||